Clinical Trials Browser

Phase 4 × Interventional × Acetaminophen Exposure × Clear all

NCT02911961 2021-09-02

APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors

Phase 4 Withdrawn

Acetaminophen Exposure